Literature DB >> 17468355

Validation of steady-state insulin sensitivity indices in chronic kidney disease.

Michael F Crutchlow1, Bruce Robinson, Binu Pappachen, Neil Wimmer, Andrew J Cucchiara, Debbie Cohen, Raymond Townsend.   

Abstract

OBJECTIVE: Insulin resistance may contribute to cardiovascular disease and the progression of renal insufficiency in patients with chronic kidney disease (CKD). However, feasible methods for estimating insulin sensitivity in large-population CKD studies have not been validated. The purpose of this study was to attempt to validate several commonly used steady-state insulin sensitivity (SI-SS) indices in a CKD population. RESEARCH DESIGN AND METHODS: Twenty-seven subjects with estimated glomerular filtration rate (eGFR) ranging from 70 to <10 ml/min per 1.73 m2 (median eGFR = 48) underwent a frequently sampled intravenous glucose tolerance test (FSIVGTT) on a single occasion. Correlations were obtained between the minimal model-derived insulin sensitivity parameter from the FSIVGTT (SI-FSIVGTT) and seven SI-SS indices derived from fasting insulin and glucose data obtained just before the FSIVGTT.
RESULTS: Each of the seven steady-state indices was significantly correlated with SI-FSIVGTT. For indices obtained using the mean of four fasting insulin and glucose values over 15 min, Pearson correlation coefficients (|r|) ranged from 0.51 to 0.87 (P < 0.01 for each). For indices using single fasting insulin and glucose values, |r| ranged from 0.51 to 0.72 (P < 0.01 for each). By both the four and one time point approaches, 1/I(0) had the highest correlation with SI-FSIVGTT. The correlation with SI-FSIVGTT did not change significantly according to eGFR level for any of the SI-SS indices.
CONCLUSIONS: SI-SS indices are valid surrogates for SI-FSIVGTT in the CKD population. Their use will expand the range of testable hypotheses in CKD cohort studies.

Entities:  

Mesh:

Year:  2007        PMID: 17468355     DOI: 10.2337/dc06-2630

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

1.  Risk factors for peripheral arterial disease among patients with chronic kidney disease.

Authors:  Jing Chen; Emile R Mohler; Dawei Xie; Michael G Shlipak; Raymond R Townsend; Lawrence J Appel; Dominic S Raj; Akinlolu O Ojo; Martin J Schreiber; Louise F Strauss; Xiaoming Zhang; Xin Wang; Jiang He; L Lee Hamm
Journal:  Am J Cardiol       Date:  2012-03-31       Impact factor: 2.778

Review 2.  Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease.

Authors:  Peng Hu; Bo Hu; Jing Wang; Ling Lu; Yuan Han Qin
Journal:  Med Sci Monit       Date:  2011-06

3.  Hyperhomocysteinemia Associated with Low Muscle Mass, Muscle Function in Elderly Hemodialysis Patients: An Analysis of Multiple Dialysis Centers.

Authors:  Chi-Sin Wang; Te-Chih Wong; Tuyen Van Duong; Chien-Tien Su; Hsi-Hsien Chen; Tso-Hsiao Chen; Yung-Ho Hsu; Sheng-Jeng Peng; Ko-Lin Kuo; Hsiang-Chung Liu; En-Tzu Lin; Yi-Wei Feng; Shwu-Huey Yang
Journal:  Biomed Res Int       Date:  2019-06-09       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.